Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer
Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study
MSI/MSS Colorectal Cancers - TRanslational ONCOlogy
Advances in immune therapies for the treatment of microsatellite instability‑high/deficient mismatch repair metastatic colorectal cancer (Review)
Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor | Anticancer Research
MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma - ScienceDirect
Both MSI and IHC -
Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers | SpringerLink
Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers | SpringerLink
Immunotherapy Combination Approved for Colorectal Cancer - NCI
Microsatellite instability: a review of what the oncologist should know | Cancer Cell International | Full Text
A molecular portrait of microsatellite instability across multiple cancers | bioRxiv
Cancers | Free Full-Text | Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
Understanding MSI-High and DNA Mismatch Repair - CancerConnect
The Importance of MSI Status
Presence of MSI-H, MMR-D Predicts Lynch Syndrome Across Tumor Types
MSI-H Biomarker | Colorectal Cancer Alliance
Microsatellite instability - Wikipedia
